1. Home
  2. TIVC vs REVB Comparison

TIVC vs REVB Comparison

Compare TIVC & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIVC
  • REVB
  • Stock Information
  • Founded
  • TIVC 2016
  • REVB 2020
  • Country
  • TIVC United States
  • REVB United States
  • Employees
  • TIVC N/A
  • REVB N/A
  • Industry
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIVC Health Care
  • REVB Health Care
  • Exchange
  • TIVC Nasdaq
  • REVB Nasdaq
  • Market Cap
  • TIVC 4.0M
  • REVB 3.8M
  • IPO Year
  • TIVC 2021
  • REVB N/A
  • Fundamental
  • Price
  • TIVC $3.22
  • REVB $2.74
  • Analyst Decision
  • TIVC
  • REVB
  • Analyst Count
  • TIVC 0
  • REVB 0
  • Target Price
  • TIVC N/A
  • REVB N/A
  • AVG Volume (30 Days)
  • TIVC 2.3M
  • REVB 164.5K
  • Earning Date
  • TIVC 08-14-2025
  • REVB 08-08-2025
  • Dividend Yield
  • TIVC N/A
  • REVB N/A
  • EPS Growth
  • TIVC N/A
  • REVB N/A
  • EPS
  • TIVC N/A
  • REVB N/A
  • Revenue
  • TIVC $462,000.00
  • REVB N/A
  • Revenue This Year
  • TIVC N/A
  • REVB N/A
  • Revenue Next Year
  • TIVC N/A
  • REVB N/A
  • P/E Ratio
  • TIVC N/A
  • REVB N/A
  • Revenue Growth
  • TIVC N/A
  • REVB N/A
  • 52 Week Low
  • TIVC $2.43
  • REVB $2.11
  • 52 Week High
  • TIVC $15.64
  • REVB $168.00
  • Technical
  • Relative Strength Index (RSI)
  • TIVC 40.16
  • REVB 51.87
  • Support Level
  • TIVC $3.39
  • REVB $2.39
  • Resistance Level
  • TIVC $5.60
  • REVB $2.70
  • Average True Range (ATR)
  • TIVC 0.38
  • REVB 0.19
  • MACD
  • TIVC 0.01
  • REVB 0.05
  • Stochastic Oscillator
  • TIVC 4.80
  • REVB 76.61

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: